· Single Sales/Supply Contract
Subsidiary Daewoong Pharmaceutical's KRW 69.2 billion Southeast Asia export deal with Abbott terminated
Subsidiary DAEWOONG PHARMA's KRW 69.2 billion Southeast Asia pitavastatin export deal with ABBOTT PRODUCTS OPERATIONS AG was terminated over weak local business, effective February 28, 2024.